These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3297633)

  • 21. Evidence for a biochemical lesion in depression.
    Leonard BE
    J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychopharmacologic treatment of depression.
    Extein I; Gold MS; Pottash AL
    Psychiatr Clin North Am; 1984 Sep; 7(3):503-17. PubMed ID: 6148743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
    Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
    Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase genes and antidepressant treatment response: a review.
    Esposito K; Reierson GW; Luo HR; Wu GS; Licinio J; Wong ML
    Ann Med; 2009; 41(3):177-85. PubMed ID: 18932104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new concept of antidepressant drugs action: clinical and preclinical data].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.
    Gardier AM
    Behav Pharmacol; 2009 Feb; 20(1):18-32. PubMed ID: 19179848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of mood disorders.
    Nemeroff CB; Owens MJ
    Nat Neurosci; 2002 Nov; 5 Suppl():1068-70. PubMed ID: 12403988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Models of antidepressant action.
    Berman RM; Charney DS
    J Clin Psychiatry; 1999; 60 Suppl 14():16-20; discussion 31-5. PubMed ID: 10408421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.
    Nutt DJ; Baldwin DS; Clayton AH; Elgie R; Lecrubier Y; Montejo AL; Papakostas GI; Souery D; Trivedi MH; Tylee A
    J Clin Psychiatry; 2006; 67 Suppl 6():46-9. PubMed ID: 16848678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tetrahydrobiopterin pathway: a novel target for the treatment of depression.
    McHugh PC
    Pharmacogenomics; 2011 Dec; 12(12):1625-7. PubMed ID: 22118047
    [No Abstract]   [Full Text] [Related]  

  • 36. Involvement of prolactin and somatostatin in depression and the mechanism of action of antidepressant drugs.
    Faron-Górecka A; Kuśmider M; Solich J; Kolasa M; Szafran K; Zurawek D; Pabian P; Dziedzicka-Wasylewska M
    Pharmacol Rep; 2013; 65(6):1640-6. PubMed ID: 24553012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression and its pharmacological management.
    Hart GA
    S Afr Med J; 1984 May; 65(20):811-4. PubMed ID: 6729612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of depression: the current state and perspectives of the development of pharmacological studies].
    Ivanetz NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):108-16. PubMed ID: 25614913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relation of therapeutic and hormonal reactions to thymoleptics in patients with endogenous depression. II. Secretion of gonadotropins and prolactin].
    Horodnicki JM; Jarema M; Czekalski S; Szakowski A; Pobocha J; Warnecka-Przybylska M; Wdowiak J
    Psychiatr Pol; 1988; 22(3):205-9. PubMed ID: 3227061
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible contribution of IGF-1 to depressive disorder.
    Szczęsny E; Slusarczyk J; Głombik K; Budziszewska B; Kubera M; Lasoń W; Basta-Kaim A
    Pharmacol Rep; 2013; 65(6):1622-31. PubMed ID: 24553010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.